| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/01/2010 | US20100166705 Culturing circular ssDNA viruses for the production of vaccines |
| 07/01/2010 | US20100166704 Methods and compositions for inhibition of viral replication |
| 07/01/2010 | US20100166703 Use of il-6/il-6 chimera in huntington's disease |
| 07/01/2010 | US20100166702 Alkylated interleukin-18 and related compositions, kits, and methods of making and using same |
| 07/01/2010 | US20100166701 Method for treating renal cell carcinoma using glycogenolysis inhibitors |
| 07/01/2010 | US20100166700 Acryloyloxyethylphosphorylcholine Containing Polymer Conjugates and Their Preparation |
| 07/01/2010 | US20100166699 Pharmaceutical combinations comprising pyrazole derivatives as protein kinase modulators |
| 07/01/2010 | US20100166698 New compositions and methods for the treatment of inflammation |
| 07/01/2010 | US20100166697 Combination therapy using tnf and alfa-galactosyl ceramide |
| 07/01/2010 | US20100166694 Diagnostic markers of wound infection |
| 07/01/2010 | US20100166681 Anhydrous Multiphase Gel System |
| 07/01/2010 | US20100166675 Pharmaceutical Composition for the Treatment of Type 1-Diabetes |
| 07/01/2010 | US20100166649 Method to inhibit cancer targeting cd24 |
| 07/01/2010 | DE102004004509B4 Einsatz von niedrig dosiertem Erythropoietin zur Stimulation endothelialer Vorläuferzellen sowie zur Organregeneration und Progressionsverlangsamung von Endorganschäden Use of low-dose erythropoietin for stimulation of endothelial progenitor cells and the organ regeneration and slowing progression of organ damage |
| 07/01/2010 | CA2747995A1 Antibiotic compositions for the treatment of gram negative infections |
| 07/01/2010 | CA2747951A1 Compounds and methods for the treatment of autoimmune and inflammatory disease |
| 07/01/2010 | CA2745557A1 Process for the preparation of a peptide powder form |
| 06/30/2010 | EP2202308A2 Methods and compositions for polypeptide engineering |
| 06/30/2010 | EP2202242A1 Inactivation resistant factor VIII related applications |
| 06/30/2010 | EP2202241A2 Therapeutic compounds and methods for modulating V3, a versican isoform |
| 06/30/2010 | EP2201960A1 Conformationally constrained parathyroid hormones with alpha-helix stabilizers |
| 06/30/2010 | EP2201959A2 Use of IL-12 and IL-12 antagonists for the manufacture of a pharmaceutical composition for the treatment of autoimmune diseases |
| 06/30/2010 | EP2201958A1 Method for the preparation of pro-apoptotic protein carrying systems and their uses |
| 06/30/2010 | EP2201953A1 Use of ribavirin in blood coagulation disorder |
| 06/30/2010 | EP2201940A1 Composition of biocompatible microparticles of alginic acid for the controlled release of active ingredients by intravenous administration |
| 06/30/2010 | EP2201897A2 Tumor targeted photodiagnostic-phototherapeutic agents |
| 06/30/2010 | EP2201562A2 Insulin-like growth factor binding protein 7 for treatment of cancer |
| 06/30/2010 | EP2201109A1 Truncated secretory aspartyl proteinase 2 |
| 06/30/2010 | EP2201035A1 Novel avian cytokines and genetic sequences encoding same |
| 06/30/2010 | EP2201034A1 Neuroprotection using nap-like and sal-like peptide mimetics |
| 06/30/2010 | EP2201033A2 Methods of treating cancer using notch pathway inhibitors |
| 06/30/2010 | EP2201026A1 Novel p2x7 epitopes |
| 06/30/2010 | EP2201025A1 Functional lipid constructs |
| 06/30/2010 | EP2200651A2 Use of hydrophobin polypeptides as penetration enhancers |
| 06/30/2010 | EP2200649A2 Compositions and methods for ameliorating cns inflammation, psychosis, delirium, ptsd or ptss |
| 06/30/2010 | EP2200648A1 Mitogen-activated protein kinase kinase kinase 14 (map3k14) polymorphisms as indicators of subject outcome in critically ill subjects |
| 06/30/2010 | EP2200634A1 Targeted interferon demonstrates potent apoptotic and anti-tumor activities |
| 06/30/2010 | EP2200632A2 The use of a non-glycanated polypeptide for treating a cancer |
| 06/30/2010 | EP2200630A1 Treatment of cardiovascular disorders using the cell differentiation signaling protein nell1 |
| 06/30/2010 | EP2200628A2 Disease treatment via antimicrobial peptides or their inhibitors |
| 06/30/2010 | EP2200626A2 Analogues of exendin-4 and exendin-3 |
| 06/30/2010 | EP2200583A1 Stable formulations of amylin and its analogues |
| 06/30/2010 | EP2200580A2 Method for the immobilization of bioactive molecules within a polymeric substrate resistant to the stomach acids as oral drug delivery system |
| 06/30/2010 | EP2200442A2 Bacteriophage or lytic protein derived from the bacteriophage which effective for treatment of staphylococcus aureus biofilm |
| 06/30/2010 | EP2200431A1 Novel compositions and methods for cancer treatment |
| 06/30/2010 | EP2200427A1 Use of neuregulin for organ preservation |
| 06/30/2010 | EP1516881B1 Composition and method for modulating dendritic Cell-T cell interaction |
| 06/30/2010 | EP1399183B1 Chimeric alphavirus replicon particles |
| 06/30/2010 | EP1036164B1 Chemokine alpha-5 |
| 06/30/2010 | CN1911442B Lysostaphin freeze dried powder used for preventing and treating trauma surface infestation |
| 06/30/2010 | CN1548534B Reptilase and its production process and application |
| 06/30/2010 | CN101765607A HPV epitopes targeted by t cells infiltrating cervical malignancies for use in vaccines |
| 06/30/2010 | CN101765434A Composition of tumour-associated peptides and related anti-cancer vaccine |
| 06/30/2010 | CN101765429A Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition |
| 06/30/2010 | CN101765375A Iron fortification nutritional blend |
| 06/30/2010 | CN101759812A Novel chitosan derivative simulating the structure of cell-penetrating peptide |
| 06/30/2010 | CN101759806A Cytoplasm leader peptide (CTD)-containing human epidermal growth factor fusion protein (CTD-hEGF) prepared by using hydroxylamine cutting method and application thereof |
| 06/30/2010 | CN101759805A Long-acting thymosin alpha1-polyethylene glycol modifiers |
| 06/30/2010 | CN101759801A Separation and purification method of novel soybean trypsin inhibitor |
| 06/30/2010 | CN101759779A Active spider polypeptide, preparation method and application thereof |
| 06/30/2010 | CN101759778A Active spider polypeptide, preparation method and application thereof |
| 06/30/2010 | CN101759775A Leech active small peptide and preparation method and application thereof |
| 06/30/2010 | CN101757631A Composition of biocompatible microparticles of alginic acid for the controlled release of active ingredients by intravenous administration |
| 06/30/2010 | CN101757617A Stable animal source thrombase preparation and preparation method thereof |
| 06/30/2010 | CN101757616A Safe freeze-dried mammal thrombin preparation and preparation method thereof |
| 06/30/2010 | CN101757615A Ointment for clearing nose planted staphylococcus aureus and preparing method thereof |
| 06/30/2010 | CN101757614A Hemostat and preparation method thereof |
| 06/30/2010 | CN101757613A Medicine for preventing and treating canine viral disease |
| 06/30/2010 | CN101757612A Gama-interferon high-efficient injection liquid for chickens and preparation method thereof |
| 06/30/2010 | CN101757611A Gama-interferon dry-powder inhaler for chickens and preparation method thereof |
| 06/30/2010 | CN101757610A Application of snake venom cytotoxin -CTX1 in the preparation of drugs with analgesic function |
| 06/30/2010 | CN101757609A Method for controlling residue of organic solvent in thymic peptide alpha1 microballoon |
| 06/30/2010 | CN101757608A Application of phycobiliprotein in preparation of photosensitizer for treating oral and pharyngeal cancer cell by using iodine-tungsten lamp |
| 06/30/2010 | CN101757607A Medication for treating chicken virus disease and preparation method |
| 06/30/2010 | CN101757606A Compound preparation for treating chicken viral diseases and preparation method thereof |
| 06/30/2010 | CN101757605A Medicine for preventing fish bacterial enteritis |
| 06/30/2010 | CN101757604A Immune polysaccharide intensifier and preparation method and application thereof |
| 06/30/2010 | CN101757603A Medicinal composition containing trandolapril taste-masking composition |
| 06/30/2010 | CN101757496A Formula for enhancing functions of spleen and stomach and promoting digestion and preparation method thereof |
| 06/30/2010 | CN101757029A Method for extracting transfer factors from cattle spleen |
| 06/30/2010 | CN101756912A Hemocoagulase freeze-dried powder injection and preparation method thereof |
| 06/30/2010 | CN101756884A Oral protein drug micelle preparation and preparation method thereof |
| 06/30/2010 | CN101537172B Recombinant human keratinocyte growth factor-2 containing eye drops and method for preparing same |
| 06/30/2010 | CN101210044B Polypeptide and application thereof |
| 06/30/2010 | CN101200720B Mitochondrial membrane potential decrease related polynucleotide as well as coded polypeptide and uses thereof |
| 06/30/2010 | CN101085343B SOD health care composition |
| 06/29/2010 | US7745708 Self-assembly of peptide-amphiphile nanofibers under physiological conditions |
| 06/29/2010 | US7745699 Herbicide metabolizing proteins; ferredoxins; methylation, dehydrogenation; kits |
| 06/29/2010 | US7745694 Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants |
| 06/29/2010 | US7745691 Genetically modified mouse lacking diacylglycerol acyltransferase-1 (DGAT-1) activity |
| 06/29/2010 | US7745689 Nephropathy-associated gene |
| 06/29/2010 | US7745609 DNA, RNA or chimeric oligonucleotide that is at least 90% complementary the nucleic acid encoding CD40 antigens, used for inhibiting the expression of CD40 in cells or tissues; antitumor and antiproliferative agents |
| 06/29/2010 | US7745604 genetic enhancers comprising the nucleotide sequences that elevates transcription of a heterologous coding sequence in a host cell |
| 06/29/2010 | US7745593 Feline CTLA-4 nucleic acid and polypeptides |
| 06/29/2010 | US7745588 Antibodies to a paralytic peptide |
| 06/29/2010 | US7745585 humanized, chimeric, genetic engineered, monoclonal or polyclonal antibody, or fragment, useful in the therapy of cancer, fibrosis and chronic obstructive pulmonary disease |
| 06/29/2010 | US7745581 T-bet compositions and methods of use thereof |
| 06/29/2010 | US7745580 polypeptide comprising an amino acid sequence that comprises lymphoctye epitopes and is capable of inducing an immune response against a molecule expressed on the surface of an intact erythrocyte infected by a placental parasite; vaccines |
| 06/29/2010 | US7745578 a mixture of a heat shock protein and a carrier, used to promote migration of cells from stents and specific sites including sites of inflammation, infection, an autoimmune reaction, a tumor and a transplanted organ or tissue |
| 06/29/2010 | US7745577 cyclic peptide having amino acid sequences amidated or hydroxylated at the carboxy terminus and conjugated to a detectible agent and/or a cytotoxic agent, used for detecting tumors and preventing transformation of normal cells into tumor cells |